Zhu Chanyan,Qu Jichen,Cao Haixia,et al.. Is non-alcoholic fatty liver disease the risk factor for the occurrence of primary bronchogenic carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 683-686.
[1] Dela Cruz CS,Tanoue LT,Matthay RA. Lung cancer: epidemiology,etiology,and prevention. Clin Chest Med,2011,32:605-644. [2] Ferlay J,Shin HR,Bray F,et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008. Int J Cancer,2010,127:2893-2917. [3] Sangodkar J,Katz S,Melville H,et al. Lung adenocarcinoma:lessons in translation from bench to bedside. Mt Sinai J Med,2010,77:597-605. [4] Cao HX,Fan JG. Editorial: Fatty liver disease:a growing public health problem worldwide. J Dig Dis,2011,12:1-2. [5] Wang FS,Fan JG,Zhang Z,et al. The global burden of liver disease:the major impact of China. Hepatology,2014,60:2099-108. [6] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版). 中华肝脏病杂志,2010,18:163-166. [7] 曾民德. 非酒精性脂肪性肝病:回顾历史, 展望未来. 实用肝脏病杂志,2016,19(2):129-131. [8] 梁乾飞,赵彩彦. 非酒精性脂肪性肝病与肝细胞癌的发生. 实用肝脏病杂志,2016,19(1):113-116. [9] Ding W,Fan J,Qin J. Association between nonalcoholic fatty liver disease and colorectal adenoma:a systematic review and meta-analysis. Int J Clin Exp Med,2015,8(1):322-333. [10] 朱婵艳,瞿冀琛,曹海霞,等. 不同病理学类型肺癌患者合并代谢综合征和非酒精性脂肪性肝病发生率调查. 实用肝脏病杂志,2016,19(3):288-291. [11] 林冬梅. 国际多学科肺癌组织病理新分类解读. 中国肺癌杂志,2013,16:277-281. [12] WHO/IASO/IOTF. The Asia-pacific perspective:redefining obesity and its treatment(article online),2003. [13] Pao W,Miller V,Zakowski M,et al. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A,2004,101:13306-13311. [14] Kosaka T,Yatabe Y,Endoh H,et al. Mutations of the epidermal growth factor receptor gene in lung cancer:biological and clinical implications. Cancer Res,2004,64:8919-8923. [15] Mollerup S,Berge G,Baera R,et al. Sex differences in risk of lung cancer:Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer,2006,119:741-744. [16] Ben-Zaken Cohen S,Pare PD,Man SF,et al. The growing burden of chronic obstructive pulmonary disease and lung cancer in women:examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med,2007,176:113-120. [17] Gonlugur U,Pinarbasi H,Gonlugur TE,et al. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome. Cancer Invest,2006,24:497-501. [18] Liu Y,Inoue M,Sobue T,et al. Reproductive factors,hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women:a large-scale population-based cohort study. Int J Cancer,2005,117:662-666. [19] Alavanja MC,Brown CC,Swanson C,et al. Saturated fat intake and lung cancer risk among nonsmoking women in Missouri. J Natl Cancer Inst,1993,85:1906-1916.